Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients